| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.035 | 0.9 |